This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

MRC, MHRA and HRA joint response to Innovative Medicines Initiative draft report on facilitating the translation of advanced therapies to patients in Europe

Last updated on 5 Aug 2016

The Medical Research Council (MRC) working with the Medicines and Healthcare Products Regulatory Agency (MHRA) and Health Research Authority (HRA) has submitted a joint response to the Innovative Medicines Initiative (IMI) consultation on Advanced Therapies Concept Paper.

This concept paper is part of a project to identify how the IMI can support the EU to realise the benefits of advanced therapies for patients. The concept paper and joint response is available to read on the Medical Research Council website.

Back to news & updates